Amway Korea Launches Two New Gut Health Products Based on Data from 110,000 Koreans

By Kim Hyuna Posted : September 1, 2026, 14:52 Updated : September 1, 2026, 14:52

Amway Korea is introducing new gut health products utilizing microbiome data from 110,000 Koreans.


On September 1, Amway Korea announced the launch of two new products under its health supplement brand Nutrilite: 'Nutrilite Begin' and 'Nutrilite Probiotics,' collectively referred to as the 'Comprehensive Gut Solution.' 'Begin' is designed to create an optimal environment for beneficial bacteria, while 'Probiotics' directly supplies live bacteria.


The development of these products draws on over 90 years of research by Nutrilite into plant nutrients and gut microbiomes. 'Nutrilite Begin' is a prebiotic product that serves as food for beneficial bacteria, focusing on creating a favorable gut environment with plant-based ingredients, including short-chain fructooligosaccharides and a fermented green blend. A four-week trial involving 100 healthy adults showed an increase in acetate and lactate, which are involved in butyrate production.


'Nutrilite Probiotics' incorporates selected strains of beneficial bacteria based on Korean microbiome data. Amway Korea has accumulated over 110,000 data points through its partnership with microbiome specialist HEM Pharma, which offers personalized gut health services. From this data, 3,428 strains were analyzed to identify two key strains, for which Amway secured exclusive global licenses. The new product contains five strains of probiotics, guaranteeing 10 billion live bacteria (CFU) per daily serving.


Amway researchers validated the effectiveness of consuming both products together using gastrointestinal models and human intestinal organoids (mini-organs). The results indicated that the combined intake significantly increased the production of butyrate, a compound crucial for gut health, compared to consuming each product separately. Two related research papers have been published in international journals.


Shin Eun-ja, CEO of Amway Korea, stated, "We aim to contribute to the expansion of the gut health management ecosystem through a two-track strategy that offers easy-to-start gut health solutions for everyone without the need for specialized testing or consultations, as well as personalized solutions based on individual health conditions."





* This article has been translated by AI.

Copyright ⓒ Aju Press All rights reserved.